BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 36625610)

  • 1. [Evaluation of long-term results of the use of entomological drug in the combination therapy of patients with benign prostatic hyperplasia and chronic prostatitis].
    Kuzmenko AV; Kuzmenko VV; Gyaurgiev TA; Kuzmenko GA
    Urologiia; 2022 Dec; (6):30-35. PubMed ID: 36625610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Entomological drug adenosine for the treatment of patients with benign prostatic hyperplasia and chronic prostatitis].
    Kuzmenko AV; Kuzmenko VV; Gyaurgiev TA
    Urologiia; 2021 Mar; (1):39-44. PubMed ID: 33818933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The use of bioregulatory peptides in the treatment of men with benign prostatic hyperplasia and chronic prostatitis].
    Kuzmenko AV; Vinnik YY; Kuzmenko VV; Gyaurgiev TA
    Urologiia; 2021 Jun; (3):70-74. PubMed ID: 34251104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effectiveness of the integrated approach to the treatment of chronic prostatitis, including in patients with benign prostatic hyperplasia].
    Zhiborev AB; Martov AG
    Urologiia; 2018 Oct; (4):81-87. PubMed ID: 30761794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multidisciplinary approach to prostatitis.
    Magri V; Boltri M; Cai T; Colombo R; Cuzzocrea S; De Visschere P; Giuberti R; Granatieri CM; Latino MA; Larganà G; Leli C; Maierna G; Marchese V; Massa E; Matteelli A; Montanari E; Morgia G; Naber KG; Papadouli V; Perletti G; Rekleiti N; Russo GI; Sensini A; Stamatiou K; Trinchieri A; Wagenlehner FME
    Arch Ital Urol Androl; 2019 Jan; 90(4):227-248. PubMed ID: 30655633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical features of benign prostatic hyperplasia complicated by chronic prostatitis].
    Chang DG; Li GS; Zhang PH; Wu TL; Mei XF; Cao J; Gao P
    Zhonghua Nan Ke Xue; 2010 Sep; 16(9):830-3. PubMed ID: 21171270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [An observational randomized study of the efficacy and safety of the drug Longidase, vaginal and rectal suppositories 3000 iu in the treatment of patients with symptoms of the lower urinary tract on the background of benign prostatic hyperplasia].
    Kuzmenko AV; Kuzmenko VV; Gyaurgiev TA; Vinnik YY
    Urologiia; 2021 Dec; (6):57-65. PubMed ID: 34967166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The efficiency of various cytokine therapy regimens in the complex treatment of men with chronic abacterial prostatitis].
    Gyaurgiev TA; Kuzmenko AV; Kuzmenko VV
    Urologiia; 2023 Mar; (1):12-19. PubMed ID: 37401678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of inflammation in lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) and its potential impact on medical therapy.
    Ficarra V; Rossanese M; Zazzara M; Giannarini G; Abbinante M; Bartoletti R; Mirone V; Scaglione F
    Curr Urol Rep; 2014 Dec; 15(12):463. PubMed ID: 25312251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can Botulinum Toxin A Still Have a Role in Treatment of Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia Through Inhibition of Chronic Prostatic Inflammation?
    Chiang BJ; Kuo HC; Liao CH
    Toxins (Basel); 2019 Sep; 11(9):. PubMed ID: 31546892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammation is a target of medical treatment for lower urinary tract symptoms associated with benign prostatic hyperplasia.
    De Nunzio C; Salonia A; Gacci M; Ficarra V
    World J Urol; 2020 Nov; 38(11):2771-2779. PubMed ID: 32060633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Baseline Basal Cell Hyperplasia Is not Associated With Baseline Lower Urinary Tract Symptoms, Baseline Clinical Prostatitis or Prostate Cancer in Repeat Biopsies.
    Freitas D; Andriole GL; Freedland SJ; Neto BS; Moreira DM
    Urology; 2019 Jul; 129():160-164. PubMed ID: 30914334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Calcium Oxalate on Expression of Clusterin and Lower Urinary Tract Symptoms in Prostatitis and Benign Prostatic Hyperplasia Patients with Calculi.
    Sun C; Xie G; Huang F; Liu X
    Med Sci Monit; 2018 Dec; 24():9196-9203. PubMed ID: 30560838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Our experience of using hexane extract of Serenoa Repens fruit (Permixone) in the treatment of LUTS in clinical practice].
    Kuzmenko AV; Gyaurgiev TA; Kuzmenko GA
    Urologiia; 2022 May; (2):84-89. PubMed ID: 35485819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The overlapping lower urinary tract symptoms of benign prostatic hyperplasia and prostatitis.
    Nickel JC
    Curr Opin Urol; 2006 Jan; 16(1):5-10. PubMed ID: 16385194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary microbiota and prostatic diseases: the key for the lock? A systematic review.
    Mjaess G; Karam A; Roumeguère T; Diamand R; Aoun F; McVary K; Moul JW; De Nunzio C; Albisinni S
    Prostate Cancer Prostatic Dis; 2023 Sep; 26(3):451-460. PubMed ID: 36209236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination therapy with tamsulosin and traditional herbal medicine for lower urinary tract symptoms due to benign prostatic hyperplasia: A double-blinded, randomized, pilot clinical trial.
    Lee CL; Shin HK; Lee JY; Kwon O; Seo CS; Kim AR; Seo BN; Yang SW; Song KH; Lim JS; Park JM; Na YG; Shin JH
    Int J Urol; 2022 Jun; 29(6):503-509. PubMed ID: 35297106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A trial of using EHF therapy in patients with benign prostatic hyperplasia and its combination with chronic prostatitis].
    Loran OB; Dunaevskiĭ IaL; Segal AS
    Urol Nefrol (Mosk); 1996; (6):37-9. PubMed ID: 9036608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic Prostate Inflammation is Associated with Severity and Progression of Benign Prostatic Hyperplasia, Lower Urinary Tract Symptoms and Risk of Acute Urinary Retention.
    Nickel JC; Roehrborn CG; Castro-Santamaria R; Freedland SJ; Moreira DM
    J Urol; 2016 Nov; 196(5):1493-1498. PubMed ID: 27378134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of PSA values by combination pharmacological therapy in patients with chronic prostatitis: implications for prostate cancer detection.
    Magri V; Trinchieri A; Montanari E; Del Nero A; Mangiarotti B; Zirpoli P; de Eguileor M; Marras E; Ceriani I; Vral A; Perletti G
    Arch Ital Urol Androl; 2007 Jun; 79(2):84-92. PubMed ID: 17695414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.